Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Gene Polymorphism-related Individual and Interracial Differences in the Outcomes of Androgen Deprivation Therapy for Prostate Cancer.

Clinical genitourinary cancer - 1 Jun 2017

Fujimoto Naohiro, Shiota Masaki, Tomisaki Ikko, Minato Akinori

Abstract excerpt

Among patients with prostate cancer, the prognosis after androgen deprivation therapy differs significantly among individuals and among races; however, the reasons underlying these differences are poorly understood. Several single nucleotide polymorphisms in genes associated with prostate cancer progression or castration resistance might serve as the host factor that influences prognosis and, thus, accounts for...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Androgen Antagonists
Share to Disease Progression

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Pharmacogenomic Variants

Share to Polymorphism, Single Nucleotide

Share to Precision Medicine

Share to Prognosis

Share to Prostatic Neoplasms

Share to Treatment Outcome

Source

Identifiers

PMID: 28188049
DOI: 10.1016/j.clgc.2017.01.006

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Gene Polymorphism-related Individual and Interracial Differences in the Outcomes of Androgen Deprivation Therapy for Prostate Cancer.PMID 28188049Read ↗

Impact of Candidate Genetic Polymorphisms in Prostate Cancer: An Overview.Semantic proximity Read ↗

Molecular Discriminators of Racial Disparities in Prostate Cancer.Semantic proximity Read ↗

The role of single nucleotide polymorphisms in predicting prostate cancer risk and therapeutic decision making.Semantic proximity Read ↗

Molecular markers in sex hormone pathway genes associated with the efficacy of androgen-deprivation therapy for prostate cancer.Semantic proximity Read ↗

Common genetic polymorphisms and prognosis of sporadic cancers: prostate cancer as a model.Semantic proximity Read ↗

Molecular epidemiology of prostate cancer: androgens and polymorphisms in androgen-related genesSemantic proximity Read ↗

Polymorphisms in androgen signaling pathway predisposing to prostate cancer.Semantic proximity Read ↗

Racial disparities in prostate cancer: a molecular perspective.Semantic proximity Read ↗

PTBP1 Genetic Variants Affect the Clinical Response to Androgen-deprivation Therapy in Patients With Prostate Cancer.Semantic proximity Read ↗

Prostate Cancer Disparities by Race and Ethnicity: From Nucleotide to Neighborhood.Semantic proximity Read ↗

Personalized prostate cancer screening: improving PSA tests with genomic information.Semantic proximity Read ↗

Connecting Gene Variation to Treatment Outcomes in Metastatic Castration-Resistant Prostate Adenocarcinoma: Insights into Second-Generation Androgen Receptor Axis-Targeted Therapies.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.